['4C]monoglucuronide, no transfer or exchange of the ['4C]glucuronosyl group between injected and endogenously produced bilirubin monoglucuronide could be detected in the excreted bilirubin diglucuronide. Third, in homozygous Gunn rats, injected "4Clabeled or unlabeled bilirubin monoor diglucuronides were excreted in bile unchanged (except that diglucuronide was hydrolyzed to a minor degree). This indicates that Gunn rats, which lack bilirubin UDPglucuronosyltransferase activity, are unable to convert injected monoglucuronide to diglucuronide. Collectively, these findings establish that a transglucuronidation mechanism is not operational in vivo and support the concept that bilirubin diglucuronide is formed by a microsomal UDP-glucuronosyltransferase system.
INTRODUCTION
Bilirubin,' the principal degradation product of heme in mammals (1) , is excreted in bile largely in the form of polar derivatives in which one or both propionic acid ,8-substituents of the pigment are esterified with a sugar, predominantly glucuronic acid (2, 3) . This conjugation is thought to disrupt the multiple intramolecular hydrogen bonds responsible for the nonpolar character of bilirubin and thereby renders the pigment excretable in bile (4) . It is well established that formation of bilirubin monoglucuronide (BMG) is catalyzed by microsomal uridine diphosphate (UDP)glucuronosyltransferase [UDP-glucuronate /3-glucuronosyltransferase (acceptor unspecific), EC 2.4.1.17], with UDP-glucuronic acid (UDPGlcUA) serving as sugar donor (5) . It remained unexplained, however, whv on incubation of liver homogenate or microsomiies frolm humans, rats, dogs, and cats with UDPGlcUA, the reaction product was largely BMG (6) , while in these species bile contains predominantly bilirubin diglucuronide (BDG) (2, 3, (7) (8) (9) . Because of this apparent inconsistenicy between the findings in vivo and in vitro, it has been postulated that conversion of B.MG to BDG is catalyzed by a separate enzyme that differs fromii bilirubin UDP-glucuronosyltransferase. Recenitly , it has been reported that in rat liver, synthesis of BDG f'rom BMG is catalyzed by BMIG glucuronosyltransf'erase, an enzyme which is distinct from microsomiial UDP-glucuronosyltransferase in its reaction mechanismii and subcellular location (10) . This enzyme is believed to convert BMG to BDG by transf'er of' a glucuronisyl group from one BMG molecule to aniother, whereby 1 mol of bilirubini aind 1 mol of BDG are f'ormed f'rom 2 mol of BMG. This transglucuroniidlationi reaction does not require UDPGlcUA as sugar dconor, aind the enzymile involved exhibits highest specific activity in the plasma membrane fraction. The reported reactioni rate of'BMG glucturonosyltransf'erase in rat aind humain liver f:ar exceeds that of' microsomal bilirubin UDP-glucuroniosyltransf'erase. An unimilpaired rate of' conversion of' BMG to BDG in vitro hals been observed in liver preparations f'rom patients with Crigler-Naijjir disease type 1 and f'rom homozygous Gunn rats (11) , 1)oth of whiclh lack detectable hepatic bilirubin UDP-glucturonosvltranisf'erase activity.
Several well-established observations in humansi anid rats in vivo have indlicated that, in the presence of' either a high hepatic bilirubin conicentration or reduce(d mnicrosomial bilirtubin UDP-glucturoniosyltransferase activity, the liver preferenitially formns BMG (9, (12) (13) (14) (15) (16) . Theref'ore, we examinied the microsomn-al UDP-gltuctironosyltranisf'erase system of'rat liver to see whether, undi(ler the standard assay conditionis, the pref'erential formncationi of BMGI is related to the uniiphysiologicallv high bilirubfin substrate coincenitrationis used. ' We fotund that wheni the pigmnenit substrate conicentrationi in the incubation Imlediumiil was substantially (lecreased, liver mierosomiies formnc approximately e(lqtal amiiounts of'B\IG anll BDG firom bilirtubin andl readily convert addled B.MG to BDG (17) . Both reactions are critically dependenit on UDPGlcUA, as neither liver hlomogenate nor mnicrosomiies conivert bilirubin or BNIG to BDG in the absence of'addledl UDPGlcUA. Mloreover, synthesis in vitro of' BDG fromn BMG was found to be deficienit ini homnozygouis Gunnli rats. These findings in vitro stuggestedl that formation of both B.NIG aindl BDG is catalyzedl by a microsomiial U DP-glucuroniosyltransferase systemii, dlistinct f'rom BXIG glucuronosyltransferase.
Conflictinig resuilts have also been reported on the conversioin of BIG to BDG in vivo. Whereas Ostrow acndl Murphy (18) couldel not detect conversion of injectedl BXIG to BDG in homozvgous Gunnll rats, Chowdhur'v et al. (11) reported formation of BDG from administered BMG in amounts comparable to those in normal rats.
The present study was undertaken to clarify the mechanism of BDG formation in vivo. Experiments were devised to examine whether BDG is synthesized in vivo in normal rats by transglucuronidation of BMG, and whether homozygous Gunn rats can convert administered BMIG to BDG.
Experimiental approach
In intact normal rats we carried out two different types of' experiments designed to detect transfer of glucuronosyl residues betweeni BMG molecules (transglucuronidationi). The first approach (series I) was based on the dissymmiletry of bilirubin, wlhich is due to the different sequence of' the mnethyl and vinyl 8-substitueints oIn the outer pyrrolinoine rings. The molecule thus contaiins two dissimilar (lipyrivlm-ietheines, which we shall designate as A (with endovinyl side chain) and B (with exovinyl side chaini), respectively. For convenience the comiiplete molecule is denoted as A-B ( Fig.  1 ). Bilirubin monoglucuronide theref'ore exists in two isomeric f'orms that diff'er by the attachment of the sugar mnoiety to either the A or the B dipyrmylmethene.2 Both isomers are formed when liver homnogenate or microsomiies are inculbated with bilinibin and UDPGlcUA (17, 19) , anl 1)oth have been idlentified in rat bile (8, 9) . For unknown reasons, the moinoglucuronide con-jugated in A uisually predominiiates (9, 17, 19) .
If'BDG were f'ormed by a tranisglucuronidatioin mechianisin, 14C-labeled glucuroniosyl groups f'or exacmple, attached exclusively to dipvrrvlmlethene A of' injected BMG would be tranisf'erredl to both the A and B halves of' other BCIG molecules. However, since the two isoinieric bilirubiin miioinoglucuroinides have Inot beenI isolated or syinthesized individually, BMG with a radiolabeled conijugatinig group attaclhed exclusively to either the A or B dipvrrylmethene is not available. We tlheref'ore used as mnodel comiipounds the radiolabeled monoglucuroinides of' the symmiiiietrical bilirubin-IIIa aind -XI11a ( Fig. 1 ). Sinice each of'these molecules conltaiins either two B or two A dlipvrrylmnethenes, the radliolabele(l glucuronosyl group is attached solely to B in the Illa anid to A in the XIIIa isomiier. Physiologically, the bilirubin-IIIa anid -XIIIa isomers and their monioglucuroniides behave simiiilatrly to the corresponding IXa isomiiers (Restults).
Rats providedl witlh an externlcal bile fistultla were inijecte(l intravenoisvly with at miiixture of' equial aImlounlts of' bilirtubin-XII11a [i4Clmonoglucuroinide [A-(®)*] anid 2 Trixviall names proposed for these two isomners are hilirul)in C-8 miioniogiLctllronii(le, correspoiidii g to the isomiier that carries the glucuronosyl group on the dipyrrylmethenie part A, and( biliruhin C-12 imionioglteiuroniide, corresponiding to the o1)posite isiomer. (Fig. 2) . The BDG excreted in the bile was isolated and the proportion of [14C]glucuronosyl groups attached to its A or B dipyrrylmethene part was determined. If BDG were formed by a microsomal, UDPGlcUA-dependent glucuronosyltransferase, all radiolabel in the excreted BDG would still be attached to the same dipyrrylmethene it had been attached to in the injected ['4C]monoglucuronide. If, on the other hand, ['4C]glucuronosyl groups had been transferred from the injected radiolabeled monoglucuronide to other administered or endogenous unlabeled monoglucuronide molecules, this transglucuronidation would be reflected by the occurrence of 14C label on both A and B dipyrrylmethenes in the excreted BDG.
In Fig. 2 , two different schemes are presented for predicting transfer of radiolabel from injected [14C]monoglucuronide to other monoglucuronide molecules by a hypothetical transglucuronidation mechanism. In both schemes it is assumed that 40% of the injected 2 Schemes predicting the distribution of l4C-labeled glucuronosyl residues between dipyrrylmethenes A and B of BDG excreted in bile if a transglucuronidation mechanism were operational in vivo. A and B (Fig. 1 ) are encircled when esterified with glucuronic acid, and an asterisk indicates that the glucuronosyl group is "4C-labeled. In both schemes it is assumed that 40% of the injected BMG is directly excreted unchanged in bile, and that 60% undergoes transglucuronidation. This assumption is required to fit the values for BMG (57%) and BDG (43%) excretion predicted by transglucuronidation ( Fig. 3 ) to the experimental findings (Tables I and III , Fig. 4 ). Scheme a depicts the expected fate of injected BMG when a mixture of 100 molecules ofbilirubin-XIIIa [14C]monoglucuronide [A-®*] and 100 molecules of unlabeled bilirubin-IIIa monoglucuronide [B-®] were injected into a normal rat, assuming that BDG is formed by a transglucuronidation mechanism and that exogenous BMG far exceeds or does not mix with endogenous BMG. Under these conditions, the predicted distribution of 14C label between A and B of BDG excreted in bile would be 75% in A and 25% in B. If a mixture of bilirubin-Illa [14C]monoglucuronide and bilirubin-XIIIa monoglucuronide were injected, the expected distribution of 14C label in BDG would be 25% in A, 75% in B. Scheme b shows the expected fate of the [I4C]glucuronosyl groups of injected bilirubin-XIIIa [14C]monoglucuronide in a transglucuronidation reaction in which endogenous BMG far exceeds the injected BMG. For the purpose of calculation, it is assumed that the C-8 isomer (esterified on the dipyrrylmethene part A) constitutes 67% oftotal endogenous BMG (9) . The predicted distribution of 14C label between A and B of BDG in bile is 67% in A and 33% in B. On the other hand, if bilirubin-IlIa [14C]monoglucuronide were injected, the expected distribution of 14C label in BDG would be 17% in A and 83% in B.
BMG is excreted unchanged in bile, whereas 60% undergoes transglucuronidation. The rationale for selecting these values is given in the legend to Fig.  3 . The two schemes differ by being based on two mutually exclusive assumptions; (a) that transglucuronidation takes place either solely between the injected bilirubin-IIIa and -XIIIa monoglucuronides without participation of endogenous BMG ( Fig. 2a) transglucuronidation occurs exclusively bet jected IIla or XIIIa monoglucuronide and e BMG molecules (Fig. 2b ). The former would hold if the amount of injected monog far exceeded the endogenous BMG produ the endogenous and exogenous monoglucu not mix. The latter assumption would app jected monoglucuronide represented a true relative to the endogenous BMG formatio schemes predict different values for the of 14C label between dipyrrylmethenes excreted BDG representing the extremes the above assumptions were correct to th of the other. If transglucuronidation wei under the actual experimental conditions expected distribution of [14C]glucuronosyl tween A and B in BDG by definition woul where between these two extreme values.
In a second approach (series II), we w beled bilirubin monoglucuronide, con in the tetrapyrrolic aglycone and 14C in the syl moiety. This was injected intravenously) ETED IN BILE larger amount of unlabeled bilirubin into rats pro-BDG vided with an external bile fistula, and BMG and BDG excreted in bile were isolated and analyzed. If BDG 30NG30 BG~w ere formed from injected BMG by a UDPGlcUA-dependent microsomal glucuronosyltransferase, the 14C:3H ratio in both the excreted BMG and BDG would be the same as in the injected pigment. On the other hand, if in-9[1GG,9 BGG jected BMG were converted to BDG by a transglucuronidation mechanism, [14C]glucuronic acid would be transferred from the dual-labeled BMG to other, unlabeled BMG molecules. The excreted BDG, therefore, would *2.7BGG,2.7BSGG exhibit a higher '4C:3H ratio and the BMG a lower isotopic ratio than that in the administered pigment. In Fig. 3 , a scheme is presented for predicting the isotope ratio of the excreted BMG and BDG formed BDG:41.7B,60O® by a transglucuronidation mechanism. This scheme is IG and BDG predicated on the administration of 100 molecules of n [14C]mono-dual-labeled BMG with a 14C:3H ratio of unity. It assglucuronida-sumes that 40% of the injected BMG is directly exre as follows: creted unchanged in bile, and that 60% undergoes [ne; © gluctransglucuronidation ( Fig. 3 , cycle I). This assumption iety. Thus, B is required to fit the values for BMG (57%) and BDG n monogluc-(43%) excretion predicted by the transglucuronidation n the assump-scheme ( Fig. 3 ) to the experimental findings (Tables I   } by a ;0% of the 14C radiolabeled BMG and unlabeled BMG because of the excess of endogenous BMG formed from the injected bilirubin. Of the 60 radiolabeled BMG molecules that enter the first transglucuronidation cycle, 30 receive a :ween an in-second unlabeled glucuronosyl group and 30 donate rndogenous their '4C-labeled conjugating moiety to unlabeled assumption BMG. The resulting 30 unconjugated [3H]bilirubin 3lucuronide molecules are then converted to [3H]BMG by UDPiction, or if glucuronosyltransferase and enter a second transironides did glucuronidation cycle. The scheme predicts that of the ly if the in-radioactivity in dual-labeled BMG molecules undertracer dose going three transglucuronidation cycles, 57% of the 3H n. The two appears in BMG and 43% in BDG; for the 14C the distribution expected distribution is 40% in BMG and 60% in BDG k and B of (Fig. 3 ). The predicted ratio of4C:3H in BMG is 0.72 if either of and in BDG 1.44 of that in the administered duale exclusion labeled BMG. These values would not be altered re to occur appreciably if cycles beyond the third were to be s used, the considered. groups be-In a third series of experiments (series III), we exd lie some-amined the controversial issue of whether homozygous
Gunn rats, which are unable to form BMG (20, 21) , sed dual-lacan convert administered BMG to BDG by transgluctaining 3H uronidation (11, 18) . The animals were injected with glucurono-16-600 nmol of unlabeled or "4C-labeled BMG, with with a much the isotope in the tetrapyrrolic aglycone, and the BMG Mechanism of Bilirubin Diglucuronide Formation in Intact Rats and BDG excreted in bile were determined. Since transglucuronidation of BMG may be impeded by the high concentration of bilirubin in Gunn rat liver, we also examined the possibility of reverse transglucuronidation, i.e., BDG + bilirubin --2 BMG; such a reaction has been claimed to occur in normal rat liver in vitro (22) . Thus, a large amount of unlabeled BDG (8.5 ,.tmol) was infused into intact Gunn rats whose endogenous bilirubin pool had been prelabeled with [14C]bilirubin. Under these conditions, reverse transglucuronidation should result in biliary excretion of 14Clabeled BMG exhibiting a specific activity one-halfthat of the [14C]bilirubin in the animal's miscible bilirubin pool. (23) . Unlabeled and 14C-labeled bilirubin-IlIa and -XIIIa were synthesized by acidcatalyzed isomerization of commercial bilirubin or [14C]bilirubin, respectively, and isolated by TLC (24) ; the purity of the isolated Illa and XIIIa isomers was established by analytical TLC with chloroform/acetic acid, 99:1 (vol/vol) as solvent, using authentic bilirubin-Illa, -IXa, and -XIIIa as references and by chromatographic analysis of the methyl esters of their ethyl anthranilate azoderivatives (25) . Unlabeled bilirubin 1-O-acyl-,3-D-monoand diglucuronide were purified from rat bile and isolated by TLC (17) . Bilirubin-IlIa or -XIIIa 1-0acyl-,8-D-[U_14C]monoglucuronide and [3H]bilirubin 1-0acyl-,3-D-[U_14C]monoglucuronide were prepared biosynthetically by incubation of the corresponding bilirubin isomers or [3H]bilirubin with "4C-labeled UDPGlcUA and microsomes from liver of normal rats, pretreated for 4 days with intraperitoneal glutethimide (7.5 mg/100 g body wt). The other components of the incubation mixture and the isolation of the product have been described (26) ; the yield of BMG was 20-30%. Identical incubation conditions were used for synthesis of (17) , such preparations contain 80-90% authentic BMG, small amounts of BDG (5-16%), and unconjugated bilirubin (1-8%). The latter two pigment fractions are formed by dipyrrole exchange of BMG during TLC, as evidenced by two-dimensional TLC of the BMG preparation and analysis of Illa, IXa, and XIIIa isomers. "Authentic BMG" is used throughout to denote the actual bilirubin monoglucuronide content of a given BMG preparation. In the BDG preparations, neither bilirubin nor BMG was detectable. After TLC, bilirubin glucuronides were eluted from silica gel with methanol and A450 was measured on an aliquot of the eluate. A known volume of the eluate was immediately evaporated to dryness under reduced pressure and the residue was dissolved in normal rat serum immediately before injection. Unconjugated bilirubin-Illa, -IXa, or -XIIIa was dissolved in chloroform and A452 was measured on an aliquot of the solution. A known volume of the solution was evaporated to dryness, the pigment residue was dissolved in a small volume of 0.1 M NaOH and then added to normal rat serum. The amount of injected pigment was determined spectrophotometrically, using reported E452 values for bilirubin isomers in chloroform (24) , and assuming E4w 60 x 103 liters mol-h cm-' for BMG or BDG in methanol.
METHODS
Animal procedures. "Normal rats" were Sprague-Dawley (380-450 g; Simonsen Labs., Gilroy, Calif.) or male Wistar B/A 300-350 g; University of Leuven, Belgium), in which bilirubin conjugates in bile are predominantly (71%) in the diconjugated form and glucuronides constitute 95-98% of the bilirubin conjugates (9) . "Gunn rats" were male homozygous Gunn rats (300-450 g) from the University ofCalifornia School of Medicine, San Francisco, or the University of Leuven. A jugular vein and the bile duct were cannulated with Intramedic polyethylene PE-10 and PE-50, respectively (Clay-Adams Div., Becton, Dickinson & Co., Parsippany, N. J.), the animals placed in restraining cages under infrared heating lamps, and infused intravenously (2 ml/h) with a 5% (wt/vol) glucose solution in 0.15 M NaCl for 2 h. Only rats producing at least 1 ml of bile/h were used. Test pigment solutions then were either injected as an intravenous bolus (0.8-1.2 ml) or infused (2 ml) over 15 min. Bile was collected in tared tubes placed in ice and bile flow was determined gravimetrically. Additional details regarding specific experiments are outlined below.
Analytical procedures. In all experiments, an aliquot of the pigment solution administered to rats was analyzed simultaneously with and by the same method(s) as bile samples; when radiolabeled pigments were injected, carrier pigments in the form of rat bile, enriched with bilirubin, were added to the samples before analysis. Total bilirubin was determined by the p-iodoaniline procedure (27) , and the ethyl anthranilate (27) and alkaline methanolysis (9) methods were used for analysis of mono-and diconjugates. When the pigments contained radiolabel in the conjugating sugar, a third procedure (28) was used in which the intact bilirubin conjugates were extracted and mono-and diglucuronides isolated by TLC using a chloroform/methanol/water, 10:5:1 (vol/vol/ vol) solvent system; with this chromatographic procedure, isomeric forms (IIIa, IXa, and XIIIa) of BMG and BDG are not separable. For determination of radioactivity in isolated BMG or BDG, a known portion of the pigment band was scraped into a counting vial and the remainder was used for structural analysis and quantitation of BMG and BDG. Azoderivatives were prepared by mixing the scraped silica gel with 1 vol of methanol and 1 vol of diazotized ethyl anthranilate reagent (27) . After 10 min at 20-25°C 1 vol of ascorbic acid solution (10 mg/ml) and 5 vol of glycine/HCl buffer, pH 2.7, (0.4 M HCl adjusted to pH 2.7 with solid glycine) were added to stop the reaction, and the azoderivatives were extracted with 2 vol of 2-pentanone. The extracted azodipyrroles were analyzed by TLC and measured spectrophotometrically (27) . For analysis of radioactivity in each individual conjugated dipyrrylmethene A or B moiety, methylated and fully acetylated derivatives of the conjugated azopigments were prepared and the isomeric azoderivatives A and B separated by TLC (26) . Preparation of samples for measurement of 14C or 3H radioactivity (Beckman liquid scintillation spectrometer model LS-250, Beckman Instruments Inc., Fullerton, Calif.) and data analysis was carried out as described (9) . Dual-label (14C 1336 N. Blanckaert, J. Gollan, and R. Schmid and 3H) counting and correctioni of count rates was performed as detailed in Beckmani Biomedical Technical Report TR-586.
Specific experiments
Details of the experiments (series I-III) outlinied in Experitental approach are given helow.
Series I. In eight normal rats provided with an external bile fistula, endogenous BMG and BDG excretion in bile during a 1-h control periodl was determinecl, and it was assumlledl that this rate of pigment excretion was maintained for the following 3 h. The animals were injected intravenou.sly with 13-70 nmol ofhilirubin-IIIa or -XIIIa [14C]monoglucuronide (8,880 dpm/nmol) and an equal amount of unlabeled monoglucuronide of the opposite isomeric type (XIIIa or lIla) (Table I). Bile was collected for 2 or 3 h and recovery of injected 14C lahel in hile was (letermineil. The intact glucuronides were extracted from hile and the radioactivity in the separatedl BMIG and BDG was measured. A portion of the isolated BMG and BDG was convertedl to ethyl anthranilate azoderivatives and the azodipyrrole gliucuroniide (azopigment-8) was isolated ancl converted to its methylated and fully acetylated derivative. The latter dlipvrrolic pigment consisted of a mixture of the two isomiieric forms of azodlipyrrole 1-O-acyl-glucuronide, correspondinig to the dipyrrylmnethene pIarts A ancl B of the parent tetrapyrroles; in their methylated andl acetylated forms, these two isomers cani he separated hy TLC for determination of radioactivitv. 14C activity in isomer A or B is expressed as a percentage of total radioactivity in the two isomers. Analysis of synthesized biliruhinll-1a or -XIIIa [14C]monoglucuronide showed that a trace amount of the 14C label was associated with the dipyrrylmnethene that, on the basis of the purity of the substrates used, had heen expected to be unlabeled. This contamination, which rangecl from 1-5% (Table  II , predicted distribhutioni of radioactivity in UDPGlcUA-dependent mechanism) in part mav have heen due to hydrolysis durinig chromatography and in part to chromatographic streaking; the latter was implied hy the observation that contamination was more pronounced with the IIIa [14C]monoglucuronide whose radiolabelecl azodipyrrolic isomiier B moves chromatographically ahead of the unlabeled isomiier A.
Ancillary experiments were carried out to ascertain that conjugation and hiliary excretion of bilirubin-Illa and -XIIIa and their monoglucuronides are c.omparable to those of the corresponding IXa isomers. [14C]hilirubin-IIIa, -IXa, -XIIIa (30-60 nmol) was administered to normal or homozygous Gunn rats and biliary excretion of these three isomers determined as descrihed (29) . In addition, excretion in bile of 3H-and 14C-labeled BMG and BDG was measured in fouir rats injected intravenously with a mixture of 75-90 nmol of [14C]bilirubin-IIIa or -XIIIa monoglucuronide and an equial amnount of [3H]hiliruhiin monoglucuronide. Aliquots of consecutively collected hile samples were radioassayecl to estimate recovery of isotope in bile.
The distribution of 3H and 14C label hetween BMG and BDG was determinied hy the ethyl anthranilate and alkaline methanolysis methods.
Series II. After a control period of 2 h, three Sprague-Dawley rats provided with an external bile fistula were injected intravenously with 1.7 ,umol of unlaheled hiliruhin and 33 nmol of [3H]bilirubin [14C]monoglucuronide, and bile was collected for 2 h. 14C and 3H in aliquots of hile were measured for estimiiation of recovery of the injected labels, and total (labeled and unlaheled) BMG and BDG excreted in bile were determinie(d both by the ethyl anthranilate and the alkaline methanolvsis methods. The intact glucuronides were extracted from the hile and fromii an aliquot of the administered sample; BMG an(d BDG were isolated by TLC and their content of 14C and 3H was measuired.
Series III. After a control period of 2-3 h, five homozygous Gunn rats (group A) were infused intravenously over 15 min with -0.5 ,umol of BMG. Bile was collected for 1 h after the start of the infusion, and the pigment in hile and an aliquot of the injected sample were analyze(d by the alkaline methanolysis and(I ethyl anithranilate methods. Recovery of the injected pigment in bile was determined hy the ethyl anthranilate method. Another five Gunn rats (group B) were injected with a small dose of [14C]B_MG (16-38 nmol; 13.5 dpm/pmol), given as a bolus. Bile was collected for the subsequent hour, the 14C in aliquots of the hile was measured for estimation of recovery of the injected radioactivity, and after addition of appropriate carrier pigments, the 14C content of the isolated 3,SD  293  67  43  43  81  66   4,SD  282  51  43  43  88  37  5,W   340  60  13  13  93  51  6,SD  185  55  45  45  94  26  7,SD   400  58  70  70  86  43  8,SD  286  49  58  58  80  25 Abbreviations used in this table: A-A, bilirubin-XIIIa; B-B, bilirubin-Illa; (A) or ®, dipyrrylmethenie part A or B that is esterified with glucuronic acid; (®)* or ®*, dipyrrylmethene part A or B that is esterified with '4C-labeled glucuronic acid; W, Wistar; SD, Sprague-Dawley. Abbreviations explained in Table I. mono-and diconjugated pigment fractions was determined.
Mechanism of Bilirubin Diglucuronide Formation in Intact Rats
In an additional experiment, two Gunn rats were injected in the tail vein with 140 nmol of ['4C]bilirubin (4.0 dpm/pmol) to prelabel their endogenous bilirubin pool (30) . 18 h later, the animals were provided with cannulae in a jugular vein and the bile duct and after a control period of 2 h, a blood sample was taken for determination of the concentration and specific activity ofserum bilirubin. Unlabeled BDG (8.5,mol) was then infused intravenously over 15 min and bile collected for 2 h. To determine the specific activities of the excreted BMG and BDG, the corresponding mono-and dimethyl esters obtained by alkaline methanolysis were saponified individually (25) ; bilirubin thus formed was isolated by TLC (24) and its specific activity determined. 2 h after administration of the BDG, the rats were anesthetized with ether and exsanguinated. For determination of the specific activity of serum bilirubin, a serum sample was subjected to alkaline methanolysis, bilirubin isolated from the extract by TLC (24), and its specific activity determined.
RESULTS
Experimental series I Comparison of the conjugation and biliary excretion of the bilirubin isomers IlIla, IXa, and XllIa. After injection of '4C-labeled bilirubin-Illa or -XIIIa in four Wistar rats, 75-88% of the label of the addministered Illa isomer and 75% of that of the XIIIa isomer appeared in bile collected over the subsequent 3 h. Approximately half (52% for the Illa isomer and 49-59% for the XIIIa isomer) of the label was excreted as BDG. In two Gunn rats, only 4 and 5%, respectively, of injected Illa or XIIIa isomer was recovered in bile in 3 h and bilirubin glucuronides could not be detected. These results are similar to those obtained with bilirubin (29) , and show that Gunn rats are unable to conjugate bilirubin-IIIa and -XIIIa. In four Sprague-Dawley rats injected with equal amounts of [3H]bili-rubin monoglucuronide and either [14C]bilirubin-Illa or -XIIIa monoglucuronide, recovery of 14C in the bile collected for 2 h ranged from 81 to 91% of the administered dose; the corresponding values for 3H recovery were 74-90%. Conversion of the Illa and XIIIa isomers to their diglucuronides and their excretion in bile were comparable to those for the co-injected IXa isomer (Fig. 4) . These findings indicated that the Illa and XIIIa isomers of bilirubin are metabolized by the liver like biliruibin, justifying their use as model comipounds in the following experiments. Diglucuronide formation from injected IIIa and XIIIa monoglucuronides in normal rats. When bilirubin-IlIa or -XIIIa [14C]monoglucuronide (Figs. 1 and 2) was injected in Wistar or Sprague-Dawley rats, 80-97% of the radioactivity was recovered in bile in 2 h; 25-66% of the excreted labeled glucuronides were diglucuronides, indicating that significant conversion of injected BMG to BDG had occurred (Table I) . The distribution of the labeled glucuronosyl group in the excreted BDG with regard to its attachment to either dipyrrylmethene A or B was virtually identical with that in the injected BMG, as expected for a UDPGlcUAdependent mechanism (Table II) . The results are inconsistent, however, with a transglucuronidation mechanism (Table II) (Table III) . During the subsequent 30-min period, only an additional 2-4% ofeach label was excreted. The BDG fraction contained 29-36% of the excreted 14C and 33-40% of the 3H, indicating that extensive conversion of injected BMG to BDG had occurred (Table III) . The 14C:3H ratio of the BMG in bile was identical to that in the administered pigment, whereas the ratio in BDG ranged from 0.78 to 0.91 of that in the injected BMG (Table III) . The slightly lower recovery of 14C compared to 3H in bile, and the "4C:3H ratio below unity in the excreted BDG (Table III) indicate that a small fraction of the glucuronides had been hydrolyzed. If this hydrolysis is taken into account, the isotope ratio of the excreted BMG and BDG is comparable to that predicted for a UDP-glucuronosyltransferase mechanism, but different from the isotope ratio expected on the basis of a transglucuronidation reaction (Table III, Fig. 3 ).
Experimental series III Excretion of injected BMG in Gunn rats. The administered pigment solution contained 90-95% authentic BMG, the remainder being made up of small amounts of bilirubin and BDG (Table IV ). In the five rats (grouip A) given a large dose of unlabeled BMG, the average recovery of the injected pigment in 1 h was 96%. The corresponding value in the five animals (group B) that received a tracer dose of 14C-labeled BMG was 85% (Table IV ). In all 10 rats the pattern ofthe excreted glucuronides, determined by two analytical methods, was similar to that of the injected conjugates, indicatinig that conversion of BMG to BDG had not occurred.
Excretion of injected BDG and ['4C]bilirubin in
Gunn rats. When unlabeled BDG was injected into two Gunn rats whose endogenous bilirubin pool had been labeled with 14C, 75-85% of the administered unlabeled pigment was recovered in bile in 2 h (Table  V) . Of this, 94% was BDG and 6% BMG (Table V) . Since virtually no label was present in the excreted BMG, it obviously had been formed by hydrolysis of the injected BDG. These findings are incomiipatible with a reverse transglucuronidation mechanismn.
DISCUSSION
The present study was made possible by the application of new and improved methods for preparation and analysis of bilirubin conjugates (9, 17, 24, (26) (27) (28) , which had not been available previously. These procedures included preparation of BMG containing 85-95% authentic monoglucuronide, which represents a substantially smaller contamination with unconjugated bilirubin and BDG than had previously been achieved (10, 11, 18, 19) . They also made it possible to prepare dual-labeled BMG containing 3H in the tetrapyrrolic aglycone and 14C in the glucuronosyl moiety, and [14C]monoglucuronides of the bilirubin-IIIa and -XIIIa isomers. Moreover, a novel, accurate method was employed for specific measurement of bilirubin and its mono-and diglucuronides (9) . This assay represents a considerably improvement over previously available procedures, including the ethyl anthranilate method (27) which may overestimate monoconjugates, particularly in pigment samples containing a relatively large amount of unconjugated bilirubin or when the prescribed requirements for sample dilution or pH control in the diazo-reaction are not rigidly observed (for a discussion, see 15, 27, 31) . Using these new experimental tools, we have demonstrated that in normal rats, injected bilirubin glucuronides are rapidly and almost quantitatively excreted in bile (Tables I and III) . A substantial fraction of the administered BMG is converted into BDG, as had previously been reported by Ostrow and Murphy (18) . It was noted, however, that the fraction of injected BMG that appeared in the bile as BDG was smaller than expected on the basis of the endogenous BDG excretion in normal rat bile (Tables I and III ). This suggests that administered BMG does not mix completely with BMG endogenously formed in the liver.
In jaundiced Gunn rats from two different colonies, injected bilirubin glucuronides were excreted in amounts comparable to those in normal rats, but no conversion of BMG to BDG could be detected (Tables  I and III-V) . Whereas these results are in agreement with previous observations (18) , they differ from those of Chowdhury et al., who reported that in Gunn rats the rate of biliary excretion of injected glucuronides is considerably smaller than in normal rats and administered BMG in part is excreted as BDG (11) . The reasons for these divergent findings are not apparent.
An incidental observation was that a minor fraction of the injected bilirubin glucuronides was hydrolyzed. In normal rats given dual-labeled BMG, this was apparent from the smaller recovery in bile of 14C, contained in the glucuronosyl moiety, as comnpared to 3H in the tetrapyrrolic aglycone of the excreted glucuronides (Table III ). The isotope ratios of the individual BMG and BDG fractions in bile suggested that hydrolysis particularly affected BDG. Similarly, infusion of BDG in Gunn rats resulted in excretion of -6% BMG (Table V) . Previous observations obtained by different experimental approaches had also suggested that bilirubin glucuronides may undergo deconjugation in the liver (32, 33) . The objective of this study was to clarify the mechanism of the conversion of BMG to BDG in intact rats. For this purpose, the pattern of bilirubin glucuronides excreted in bile was determined in rats injected either with bilirubin-Illa or -XIIIa [14C]monoglucurunide or with [3H]bilirubin [14C]monoglucuronide. While analysis of the labeled pigment conjugates in bile obviously does not permit direct assessment of the nature of the underlying enzymatic events, the present experiments were designed so that the results would exclude one of the two postulated mechanisms for BDG formation (10, 17) . It is evident that the results listed in Tables II and III rule out a transglucuronidation mechanism (10), but are consistent with a UDPGlcUAdependent enzyme system (17) . These findings and the present observation that homozygous Gunn rats in vivo cannot convert injected BMG to BDG are in agreement with the demonstrations in vitro that rat (17, 34) and cat liver (19) contain a microsomal UDP-glucuronosyltransferase system which readily converts bilirubin or BMG to BDG. Further, albeit indirect, support for the in vivo operation of this system is provided by the observations that the proportion of BMG in bile is increased in conditions associated with deficient hepatic UDP-glucuronosyltransferase activity, such as the Crigler-Najjar disease, Gilbert syndrome, and heterozygous Gunn rats (9, (14) (15) (16) , and in normal humans (12) and rats (9, 13) infused with large amounts of bilirubin. These phenomena appear incompatible with a transglucuronidation mechanism whose activity in rat liver has been reported to be considerably higher than that of UDP-glucuronosyltransferase (10, 11) . Based on the previous in vitro (17, 34) and present in vivo findings, we conclude that hepatic formation of both BMG and BDG most likely is catalyzed by a microsomal UDP-glucuronosyltransferase system.
